Parkview Health

Parkview Health Research Repository
Other Specialties

Parkview Research Center

4-1-2021

Successful Distancing: Telemedicine in Gastroenterology and
Hepatology During the COVID-19 Pandemic.
Abhilash Perisetti M.B.B.S, M.D.
Parkview Health, abhilash.perisetti@gmail.com

Hemant Goyal

Follow this and additional works at: https://researchrepository.parkviewhealth.org/other
Part of the Gastroenterology Commons, Health and Medical Administration Commons, and the
Hepatology Commons

Recommended Citation
Perisetti, Abhilash M.B.B.S, M.D. and Goyal, Hemant, "Successful Distancing: Telemedicine in
Gastroenterology and Hepatology During the COVID-19 Pandemic." (2021). Other Specialties. 19.
https://researchrepository.parkviewhealth.org/other/19

This Article is brought to you for free and open access by the Parkview Research Center at Parkview Health
Research Repository. It has been accepted for inclusion in Other Specialties by an authorized administrator of
Parkview Health Research Repository. For more information, please contact julie.hughbanks@parkview.com.

Digestive Diseases and Sciences
https://doi.org/10.1007/s10620-021-06874-x

MENTORED REVIEW

Successful Distancing: Telemedicine in Gastroenterology
and Hepatology During the COVID‑19 Pandemic
Abhilash Perisetti1 · Hemant Goyal2,3
Accepted: 19 January 2021
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021

Abstract
Telemedicine involves delivering healthcare and preventative care services to patients without the need for in-person encounters. Traditionally, telemedicine has been used for acute events (e.g., stroke, used to relay essential information to the emergency department) and chronic disease management (e.g., diabetes and chronic kidney disease management). Though the
utilization of telemedicine in gastroenterology and hepatology has been modest at best, especially for inflammatory bowel
diseases and chronic liver disease management, since the onset of coronavirus disease 2019 (COVID-19) pandemic, utilization of telemedicine in gastroenterology increased by 4000% in the first two weeks, equivalent to the last six years of growth
before the pandemic. The Center for Medicare and Medicaid (CMS) relaxed rules for the use of telemedicine with easing
restrictions on reimbursements, location, licensing requirements (across state lines), and the need for a prior provider-patient
relationship. These changes increased the use of telemedicine in inpatient and outpatient settings for gastroenterology-related
referrals. The use of inpatient telephonic or video consults helps provide timely care during the pandemic while conserving
personal protective equipment and decreasing provider and patient exposure. Nevertheless, telehealth use comes at the cost of
no direct patient contact and lesser reimbursements. The appropriate use of technology and equipment, training of healthcare
providers, use of platforms that can be integrated into the electronic health record while protecting the privacy and the flow
of information are essential components of telemedicine. Furthermore, encouraging patients to seek medical care remotely
with the proper equipment and improving digital literacy without the need for physical examinations is a challenge, further
compounded in elderly or hard-of-hearing patients and in patients who are more comfortable with in-person visits. The
authors will systematically review and discuss how telemedicine can be integrated into the practice of gastroenterology and
hepatology, with emphasis placed on discussing barriers to success and the ways they can be mitigated.
Keywords Telemedicine · Telehealth · COVID-19 · Gastroenterology · Hepatology · IBD · Pandemic · COVID-19 ·
Coronavirus · SARS-CoV-2
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Telemedicine is a term used to provide remote healthcare
to patients without the need for in-person encounters [1].
Telehealth is a broader term that includes a wide range of
methods used to communicate with patients using video portals and telephonic communication. The Health Resources
and Services Administration (HRSA) of the US Department
of Health and Human Services defines telehealth as “the use
of electronic information, telecommunications technologies
to support long-distance clinical healthcare, health-related
education, public health, and administrative purposes” [2].
The technologies used vary widely but commonly include
videoconferencing, storing or forwarding images, streaming
media, landlines, and wireless communications [2]. Though
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telemedicine and telehealth are often used interchangeably,
telemedicine is limited in its definition as “the delivery of
healthcare services, where distance is a critical factor, by all
healthcare professionals using technologies for the exchange
of diagnosis, treatment, and prevention” [3]. Among these
definitions, the decisive factor is “distance” without direct
patient contact. Telemedicine includes multiple subtypes
such as telemonitoring (patients wearing mobile devices and
reporting to their providers about symptoms/disease progression), tele-education (webinars, interactive sessions provided
to providers or patients or both), teleconsultation (remote
ICU care, ED consultation), and telecare (video interaction
to simulate a face-to-face visit in order to assist in diagnosis and treatment). Despite multiple barriers, telemedicine
offers important advantages as outlined below (Table 1) [4].
Since its introduction, telemedicine has been extensively
studied in both acute and chronic care settings. Teleconsultations are widely used in ED and ICU settings, where rapid
access to patient information is essential and could be lifesaving [4]. One of the best examples includes acute stroke
intervention provided by neurologists for patients admitted
to remote hospitals [5]. Chronic disease management via
telemedicine has gained significance in various fields such
as cardiology, endocrinology, rheumatology, nephrology,
and other areas where longitudinal metrics of patient data
are essential for evaluating trends in quality measures (e.g.,
glycated hemoglobin, serum creatinine). Telemedicine has
made inroads in the field of gastroenterology as well. Some
of the most important areas within gastroenterology where
telemedicine is utilized include inflammatory bowel disease

(IBD) [6, 7], GI motility [8], and HCV treatment monitoring [9]. The emergence of human infection with the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
in December 2019 in Wuhan, China, and its rapid evolution
into the coronavirus 2019 (COVID-19) pandemic in March
2020 significantly stressed healthcare systems [10]. Multiple
organizations recommended several public health measures
such as stay-at-home orders, social distancing, quarantines,
and containment in the USA and globally [11–13]. These
measures discouraged the face-to-face (F2F) encounters that
increased infection transmission risk.
Traditionally, the Center for Medicare and Medicaid
Services (CMS) required the following criteria to be met
to qualify for a telemedicine visit [14]: prior relationship
(providers should have an established patient relationship
with prior visits), location (patient should visit a nearby
facility to access the remote visit), and modality (video
conferencing technology should be available at the facility).
Nonetheless, CMS expanded telemedicine benefits on an
emergency and temporary basis (1135 waiver authority and
Coronavirus Preparedness Response Supplemental Appropriations Act, March 27, 2020 [H.R.6074]) so as to remove
the restriction of location (patients can receive care from
home and at any facility) with CDC recommendations to
limit in-person visits [15]. These changes, adopted by private insurers as well [16], were rapidly adopted by hospitals
and healthcare institutions in order to incorporate telemedicine into GI practice in both outpatient and inpatient settings. Due to these changes, multiple studies were published
in order to evaluate the efficacy, outcomes of telemedicine

Table 1  Advantages and barriers in telemedicine
Telemedicine
Advantages

Barriers

Access—Access to healthcare anywhere/anytime if internet connection
is available
Financial—Low cost, flexible timings for both patients and providers
Delays—Could decrease backlogs and scheduling delays, especially
during the pandemic
Stratification—Could stratify care with complex decision-making
discussions requiring in-person visits

Legal—Coverage of malpractice differs across state lines and among
insurance carriers
Financial—Reimbursement issues and cost-sharing
Licensure—Requirement of licensures across multiple states and related
paperwork
Education—Patient: Learning curve with software, need for an optimum user interface, training prior to use. Provider: Learning curve
with navigating across the software
Equipment—Appropriate use of hardware and software, the related cost
for patients and providers
Patient factors—Hearing/vision-related issues. Patient reliance on lip
reading for communication, personal preference of in-person visits
Privacy concerns—Need for HIPPA compliance, privacy issues, risk,
need for integration, risk of loss of information/hacking
Others—Loss of traditional “hands-on” physical examination, patientprovider relationship, lack of non-verbal gesture to communicate

Preferences—Options to facilitate lifestyle preferences of the patients
and avoid the commute
Monitoring—Frequent laboratory monitoring and patient education
Information sharing—Relay/ access of critical information. Option to
have multiple providers from different specialties at one time
Communication—Discussion among PCP and specialists one platform, increased engagement of patients, increased practice efficiency, and reducing no-shows

Some of these barriers are dependent on state-specific licensure rules, insurance carriers. Providers/ancillary staff could engage in discussion
with the patient prior to initiating a televisit. PCP—primary care provider, HIPPA—health insurance portability, and accountability act
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in GI diseases extending well beyond IBD and HCV management. Yet, as the pandemic unfolds in different phases,
uncertainty still exists about the most appropriate modality
of telemedicine to use, the type of technology, the equipment
needed, provider training, and audio–video compatibility.
Furthermore, patient-related issues such as getting used to
such technology, space availability, privacy concerns, and
health insurance portability and accountability act (HIPPA)related issues exist. Given these, we aim to review the recent
updates, including recently published literature on telemedicine and what could be expected in the future.

Search Strategy
A comprehensive search was performed using PubMed,
Embase, Cochrane, OVID, Web of Science, ClinicalTrials.
gov, Elsevier/Science Direct on December 6, 2020. Search
terms used were—“gastroenterology,” “gastrointestinal
disease,” “liver disease,” “liver dysfunction,” “liver transplantation,” “inflammatory bowel disease,” “Crohn’s disease,” “Ulcerative colitis,” “IBD,” “hepatitis C,” “hepatitis
C antigen,” “telemedicine,” “telehealth,” “mobile health” or
“videoconferencing.” Initial search for telehealth or mobile
health yielded 34,910 articles. A search using gastroenterology, liver disease, IBD, and hepatitis C revealed 1,520,038
articles. After combining these two searches and using filters
(human species and English language) and manual removal

of duplicates, 302 published reports were finally reviewed
in their full manuscripts.

Role of Telemedicine in Gastroenterology
During COVID‑19
Telemedicine through telephone and video has been used
since 1960 in military and space where in-person visits
were not feasible [17]. Increased availability of broadband
technology increased the connectivity of different individuals from rural to urban areas [18]. Though telemedicine in
gastroenterology has been explored only in chronic disease
management of patients with IBD, HCV, and hepatology
(Fig. 1) [19], COVID-19 provided a unique opportunity for
healthcare institutions, gastroenterologists, and patients to
adapt to online platforms to access healthcare in a safe
environment in a timely manner. COVID-19 is rapidly
changing and evolving with the emergence of extrapulmonary manifestations [20]. GI and liver symptoms have
emerged as important manifestations of COVID-19, which
can also precede respiratory symptoms, and in a few cases,
can be the only symptoms [21–23]. Furthermore, taste
changes among COVID-19 patients are observed in up to
50% of cases [24]. Hence, recognizing these symptoms
early in the disease process can help prompt identification,
isolation, quarantine, and management. Multiple studies
reported a significant decrease in endoscopy volume during the pandemic due to widespread stay-at-home orders.

Fig. 1  Contributions of telemedicine to the practice of gastroenterology, past and the present
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Moreover, due to overwhelmed healthcare systems, endoscopy units were utilized as COVID-19 units [25], with
consequent widespread delays and an increasing backlog
of elective cases [26]. These changes forced providers to
communicate with patients via telemedicine route.
Given this need, there was a pressing demand to increase
the telemedicine options available during the pandemic,
compounded by the rescheduling of elective cases and
increased wait times. Fortunately, governing bodies in the
USA (CMS), Asia, and Europe have eased the restrictions on
using and increased reimbursement opportunities to further
facilitate the use of telemedicine [15, 27]. Despite recent
explosive growth, it is unclear which model to adapt, especially in outpatient GI practice in patients without a history
of IBD or HCV. Further, uncertainty about the reimbursement platform, licensure needed, malpractice coverages,
software, and equipment needed created a steep learning
curve for the providers.

Telemedicine Models and GI Disease
Management

the need for additional evaluation prior to the consultation.
Before establishing a telemedicine visit, adequate availability of hardware such as the presence of a secure phone line,
a microphone, a video monitor, and related connections and
HIPPA-compliant software with an Internet connection is
needed [28]. Multiple platforms have been used to facilitate
this process that could be either integrated into the electronic
health record (EHR)—Epic™ (Epic Systems Corporation,
Verona, WI) virtual platform, American Well™, GI OnDemand® (American College of Gastroenterology endorsed
member benefit) or non-integrated platforms—Cisco WebEx
meetings™, Doxy.me™, Doximity™, Vsee™, Skype™,
GoToMeeting™, and Zoom for Healthcare™ (Table 2)
[29–34]. Recently, the US Department of Health eased video
visit restrictions by using applications such as Apple FaceTime, WhatsApp, Facebook Messenger, and Google Hangouts, provided they are used in good faith [15]. Once appropriate hardware and software are available, screening of the
referral should be made either by supporting staff or the GI
provider based on the time sensitivity of the diagnosis.

Patients requiring consultation by a gastroenterologist need
to be first triaged by the urgency of the consultation. Several factors should be considered, such as time sensitivity
of the diagnosis, adverse effects of delay in diagnosis, and
Table 2  Common platforms that could be potentially utilized for providing GI telemedicine
Name

Information

Epic™
American Well™
GI OnDemand™

Depending on the type of contract, it could be built into the existing Epic EHR
Used by LiveHealth online, contracts Anthem®/ Wellpoint®
An ACG-endorsed platform offers secure video, end-to-end practice management tools,
EHR integration, billing. Dedicated to the practice of gastroenterology
Cisco Webex meetings™
Provides platforms for Webex rooms, web and videoconferencing
Doxy.me™
Secure video with the built-in consent process. A free platform that supports a waiting
room workflow
Carena™, CarePaths™, Chrion Health®, CloudVisit™ Could be used for virtual platform clinics, behavioral health EHR, secure messaging,
claims, billing, and e-prescribing
DigiGone™, Doximity™, 1 Doc Way™
Subscription model used, DigiGone is used by George Washington University Maritime Medical Access to provide telemedicine
eVisit™
Medical charting, patient emails, onboarding support, 2-way video support
GoToMeeting™
Provides video conferencing, desktop sharing via unified communication and collaboration portfolio
Assists in scheduling, video calling. Secure Video® initially focused on telepsychiatry
Secure Telehealth®, Secure Video®, Sight Call™,
SnapMD™, Skype for Business/Microsoft meeting™ but expanded its offering. SightCall uses WebRTC-based video calling platforms
VSee™, VirtuMedixm®, WeCounsel™
VSee™ is used by NASA across the international space stations
Zoom for Health Care™
Offers collaborative healthcare, medical education, and population-based care
All platforms need to be compliant with HIPPA rules in order to ensure secure patient and provider communications. Due to the COVID-19
pandemic, HHS temporarily relaxed the restrictions and will not impose penalties for non-compliance provided the care is given with good faith.
The list is not complete and is subjected to change based on platform performances and individual vendors. HIPPA—health insurance portability
and accountability act, EHR—Electronic health record, NASA—National Aeronautics and Space Administration, ACG—American College of
Gastroenterology
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Outpatient GI Referrals and Practice During
COVID‑19
With COVID-19, telemedicine has been extended to increase
the spectrum of GI encounters to include patients with
abdominal pain, colorectal cancer (CRC) screening, abnormal liver tests, and GI bleeding, and liver transplant recipients. In a US study conducted by Serper et al., 94% of GI/
hepatology visits were virtual via telemedicine during the
pandemic compared to only 5% two weeks before the onset
of the COVID-19 [35].
Pre-charting by medical assistants, nurses, and providers (similar to regular in-person visits) can further decrease
documentation time and enhance meaningful discussion
with the patient [36]. An actively engaging dialogue with
the referring physicians’ office about the need for additional
testing can expedite a definitive treatment plan. A robust
EHR with direct patient messaging and available literature
can seamlessly engage the communication with referring
physicians and the patients providing high-quality care.

Inpatient GI Referrals During COVID‑19
Though telemedicine has been traditionally utilized for
dermatology, palliative care, and neurology in the inpatient setting [37, 38], the pandemic has provided a unique
opportunity for telemedicine to facilitate timely, high-quality
care to patients needing urgent GI care. The CDC added
multiple symptoms to the list of COVID-19 extraintestinal
manifestations such as nausea, vomiting, dysgeusia, hepatitis, colitis, pancreatitis, and GI bleeding [39, 40]. Moreover, COVID-19 has been associated with abnormal liver
chemistries and hyperlipasemia. COVID-19 patients with
GI symptoms (including GI bleeding) prompt urgent GI
consultations in the inpatient setting. Telemedicine can be
utilized in COVID-19 patients with GI symptoms similar to
the stroke-related care provided by the neurologists. This
need is further increased due to the shortage of COVID-19
testing kits and the need to conserve personnel protective
equipment (PPE) while minimizing exposure.
Telemedicine in the inpatient setting could be utilized in
multiple ways [30]: inpatient e-consults (involves a precise
question with a review of the medical chart and a need for
formal written note); inpatient telephonic consults (use of
a telephone to obtain relevant information with the review
of the chart and documentation of the note, appropriate for
questions involving active patient engagement); and inpatient video consults (use of video in an integrated/non-integrated platforms to obtain a full history, limited physical
examination with the assistance of bedside nurse, and documentation of full consult note) [41]. Patient care assistants

could help set up the necessary equipment and minimize
interruptions akin to settings used in acute stroke-related
care. A focused examination template for teleconsultations
has been proposed in the literature [41]. Regardless of the
type of inpatient telemedicine visit, a stable and high-speed
Internet connection combined with sensors to measure vital
signs and other physical examination aspects is required
[18]. Active communication with the referring team can be
reimbursed as complex in-person consultations [16].

Use of Telemedicine for Specific GI Disorders
During COVID‑19 Pandemic
Though traditionally, telemedicine in GI disorders is
restricted to stable, non-urgent problems in outpatient
settings, with the advent of the pandemic, this has been
extended to urgent and emergent situations as well. Inpatient-type telemedicine can be utilized to provide care for
inpatients during the pandemic, especially those who need
immediate attention, yet decrease the risk of viral transmission while conserving PPE.

IBD Care
IBD care with telemedicine has been used for many years.
The development of Home Automated Tele management
(HAT) was well accepted by IBD patients [42]. Finkelstein
et al. [43] reported using HAT in 2003 for chronic diseases
such as asthma, chronic obstructive lung disease (COPD)
and extended it to IBD care. It was originally developed for
patients with different chronic health conditions in order to
facilitate their self-care [43]. It involves using a networked
computer with an automated transfer of patient survey
results to a central server to track disease progression [6].
Multiple institutions have development platforms such as
IBD Qorus™ program centers [44], HealthPROMISE [45],
IBD LIVE™ (Liver Interinstitutional and interdisciplinary
Video conference Education) [46], and myIBDcoach [47]
in order to provide high-quality care, improve adherence to
the treatment regimens, and identify disease progression at
early stages facilitating the timely institution of therapies.
There is no better time for increased telemedicine utilization in IBD care than now [48, 49]. Although IBD patients
may be at higher risk for acquiring SARS-CoV-2 infection
due to a dysregulated immune system, biological therapy
continuation in IBD is essential. Telemedicine could
be utilized in outpatient and inpatient settings in these
patients to provide care with an emphasis on medication
adjustments (biological therapy, corticosteroid, and antiinflammatory agent use). Moreover, IBD patients using
online applications expressed the desire to increase their
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use during the pandemic [50]. Interestingly fecal calprotectin testing, an integral part of the management of IBD
patients, has been reduced during the pandemic due to a
theoretical risk of fecal transmission of SARS-CoV-2 and
contact with laboratories [50, 51]. Lewin et al. reported
that telemedicine use in IBD increased to 50% or more,
compared with < 25% in the pre-pandemic era [41]. An
international survey from 56 countries and 802 respondents reported that 0–25% of pre-pandemic IBD clinical
encounters were telemedicine compared with > 75% during the pandemic [50]. Furthermore, it is anticipated that
50% of the clinical encounters will be continued via telemedicine after COVID-19-related restrictions are lifted
[50], emphasizing the increasing utility of telemedicine
for IBD care, which will likely continue post-pandemic.

Hepatology Care
Telemedicine has been successfully used for many years in
HCV management. For example, in 2003, the University
of New Mexico Health Sciences developed a model called
“Extension for Community Healthcare Outcomes (ECHO)”
to improve access to chronic disease management (such as
hepatitis C) in rural areas of New Mexico. This model uses
the inter-disciplinary expertise of specialty providers to
assist in complex disease management of hepatitis C. Furthermore, co-management of patients with the engagement
of PCPs can facilitate interactive case-based discussions and
improving outcomes. The Veterans Affairs Health System
adopted a similar model (VAHS) called Specialty Access
Network-Extension of Community Healthcare Outcome
(SCAN-ECHO) to deliver care to patients with liver disease
[52]. Most telemedicine encounters in hepatology involve
HCV management. Few studies have evaluated telemedicine’s utility in chronic liver disease management, hepatocellular carcinoma, peri-procedural/surgical management
of patients with advanced liver disease, and determining
patients’ liver transplant status with decompensated cirrhosis [53]. Due to these changes, “telehepatology” programs
have emerged during the COVID-19 pandemic [9]. With the
advent of COVID-19, a renewed interest emerged to incorporate telemedicine beyond HCV into overall hepatology
care. Though integrated health systems such as VAHS and
Kaiser Permanente have utilized telemedicine in order to
reduce cost and increase access to patients in the past [54],
smaller systems still have challenges in achieving telemedicine in hepatology care due to multiple barriers (such as
integrating the care, limited by the type of electronic health
record system, and financial components, Table 1). It is
expected that telemedicine will be accepted for a wider range
of liver diseases with COVID-19 emergence and relaxation
of reimbursement restrictions.

13

Outpatient Gastroenterology Services
With telemedicine’s success in IBD and hepatology care,
its utility has been extended recently with the emergence
of COVID-19. Tang and colleagues reported a model for
all outpatient gastroenterology referrals over five months,
during which 1243 hybrid electronic consultations were
performed with an 887 (71%) reduction of the in-person
need for a clinic visit [36]. Furthermore, 98% of consultations were completed within 20 min. These visits were
most commonly utilized for CRC screening/surveillance and
GI symptoms such as abdominal pain and heartburn. Telemedicine is currently being employed in all non-emergent
outpatient GI visits, especially during the pandemic. Functional GI disorders such as irritable bowel syndrome (IBS),
chronic abdominal pain, and post-procedure monitoring are
all managed via telemedicine [55]. The GI conditions needing further evaluation can be followed by repeated telehealth
visits or an in-person visit if needed.

Barriers to Telemedicine
Legal challenges, reimbursement restrictions, and state
licensure requirements [55] had traditionally limited telemedicine’s widespread applicability in gastroenterology
(Table 1). Moreover, telemedicine has not yet become a
part of formal GI training, causing discomfort during visits
among novice gastroenterologists. Though these restrictions
have been relaxed during the pandemic with the remarkable growth of telehealth, other barriers (mentioned below)
persist. These could be divided into the patient and provider-related factors (Fig. 2). Patient factors— traditionally,
though inpatient visits start with a handshake, history, and
a “hands-on” physical examination that were the core of
the patients’ visit [56], the use and time spent on the physical examination have been decreasing with the growth of
technology, advanced imaging, and laboratory data. Nevertheless, the physical examination is the inherent part of the
visit, especially when testing modalities are not available
[57]. The COVID-19 pandemic changed this paradigm due
to a need to maintain social distancing and stay-at-home
orders. Furthermore, older patients can have hearing problems and sometimes rely on lip reading. The lack and the
requisite knowledge to navigate and operate necessary
electronic equipment are also a major limitation in older
patients. It can be challenging to adapt to telehealth changes
for some accustomed to traditional methods. Acceptability of telemedicine was notably low among the Black and
elderly patients, higher-risk groups for severe COVID-19,
for unknown reasons [35] [58]. These barriers can be overcome in part by medical assistants who can act as facilitators
to engage the patient in a telephone or televideo visit prior to
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the provider visit, allaying anxiety while providing technical
support, helping troubleshoot the potential issues can arise
during the video chat with the provider.
Provider factors— Similar to patient factors, providers
are familiar with the paradigm of F2F visits, often relying
on non-verbal cues to connect with their patients [16], while
keeping the patient-provider relationship intact by engaging
the patient and the family members accompanying them. A
survey of GI providers in April 2020 showed that 68% of
respondents never performed video consultations prior to
the pandemic [41]. With the increasing use of EHR, online
portal use, and communications with patients via online
messaging, the utility of telemedicine has been improving
[59]. Although video consultations can assist with nonverbal cues, including facial expressions, telephone visits are technically easier and more flexible. These factors,
combined with the need for interstate licensing, easier reimbursement policies, adoption of a similar level of reimbursements for in-person visits, and no cost-sharing for patients,
have helped telemedicine expand at a rapid pace. Despite
these promising developments, unidentified barriers, risks
of privacy loss, a breach in patient-provider relationship,
loss of information, hacking, breach of HIPPA, confusion
about ordering tests, whether referring provider or specialty
provider could occur, which can improve with continuing
multidisciplinary efforts in the future.

The Future of Telemedicine
in Gastroenterology
With all the changes noted recently, telemedicine adoption has increased significantly and is expected to rise
further. As the COVID-19 pandemic unfolds globally,
temporary relaxations of telemedicine usage restriction
will only accelerate its widespread use. Although this is
unchartered territory due to the ongoing pandemic, lessons learned from telemedicine during this public health
crisis will be used for many years. Telemedicine is a lowcost, widely available tool that can reach patients with
multiple barriers to in-person visits. If utilized properly,
with the relaxation of rules for its widespread use with the
appropriate patient and provider education, it can greatly
assist in providing patient-centric care with the improved
overall quality. Moreover, telemedicine is likely the optimal means to reduce the size of backlogs and delays inclinic appointments so far created by the pandemic. It can
prioritize the in-person visits to areas that need complex
medical care and detailed discussions. With all the available data, telemedicine is feasible, efficient, and does not
compromise the quality and clinical care needed for these
patients. The future rests with taking a proactive approach
with providing patients with options of the type of visit on
which to choose based on their lifestyle and convenience.

Fig. 2  Patient and provider factors that could favorably modify the telemedicine experience
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Further, it can reduce ED utilization while focusing on
high-quality, low-cost care. Outcomes of telemedicine use
in the COVID-19 pandemic can be taken as an opportunity by the policymakers and healthcare organizations to
develop strategies to improve access and safety in gastroenterology and hepatology specialty care.
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